Human β-defensin 3 inhibits cell wall biosynthesis in staphylococci

Infection and Immunity

Volumn 78, Issue 6, 2010, Pages 2793-2800

  Sass, Vera ^a   Schneider, Tanja ^a   Wilmes, Miriam ^a   Körner, Christian ^a   Tossi, Alessandro ^b   Novikova, Natalia ^c   Shamova, Olga ^c   Sahl, Hans Georg ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF TRIESTE   (Italy)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; BACTERIAL ENZYME; BETA DEFENSIN 3; BETA LACTAM ANTIBIOTIC; FEMX ENZYME; MRAY ENZYME; MURG ENZYME; PENICILLIN BINDING PROTEIN 2; PENTAPEPTIDE; PEPTIDOGLYCAN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLMURAMYL PENTAPEPTIDE; VANCOMYCIN;

ARTICLE; BACTERIAL CELL WALL; BIOSYNTHESIS; CARBOHYDRATE SYNTHESIS; CELL LEVEL; CELL WALL; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; STAPHYLOCOCCUS AUREUS; STOICHIOMETRY; TRANSMISSION ELECTRON MICROSCOPY;

BETA-DEFENSINS; CELL WALL; CYTOPLASM; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; STAPHYLOCOCCUS AUREUS; URIDINE DIPHOSPHATE N-ACETYLMURAMIC ACID;

EID: 77952693839     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00688-09     Document Type: Article

References (51)

1. Barak, I., K. Muchova, A. J. Wilkinson, P. J. O'Toole, and N. Pavlendova. 2008. Lipid spirals in Bacillus subtilis and their role in cell division. Mol. Microbiol. 68:1315-1327.
2. Barker, H. C., N. Kinsella, A. Jaspe, T. Friedrich, and C. D. O'Connor. 2000. Formate protects stationary-phase Escherichia coli and Salmonella cells from killing by a cationic antimicrobial peptide. Mol. Microbiol. 35:1518-1529.
3. Bierbaum, G., and H. G. Sahl. 1989. Influence of cationic peptides on the activity of the autolytic endo-beta-N-acetylglucosaminidase of Staphylococcus simulans 22. FEMS Microbiol. Lett. 49:223-227.
4. Boniotto, M., N. Antcheva, I. Zelezetsky, A. Tossi, V. Palumbo, M. V. Verga Falzacappa, S. Sgubin, L. Braida, A. Amoroso, and S. Crovella. 2003. A study of host defence peptide beta-defensin 3 in primates. Biochem. J. 374:707-714. (Pubitemid 37163915)
5. Bowdish, D. M., D. J. Davidson, and R. E. Hancock. 2005. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr. Protein Pept. Sci. 6:35-51.
6. Bowdish, D. M., D. J. Davidson, M. G. Scott, and R. E. Hancock. 2005. Immunomodulatory activities of small host defense peptides. Antimicrob. Agents Chemother. 49:1727-1732.
7. Brotz, H., M. Josten, I. Wiedemann, U. Schneider, F. Gotz, G. Bierbaum, and H. G. Sahl. 1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30:317-327.
8. Dai, D., and E. E. Ishiguro. 1988. murH, a new genetic locus in Escherichia coli involved in cell wall peptidoglycan biosynthesis. J. Bacteriol. 170:2197-2201.
9. Dorschner, R. A., B. Lopez-Garcia, A. Peschel, D. Kraus, K. Morikawa, V. Nizet, and R. L. Gallo. 2006. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J. 20:35-42.
10. Ganz, T. 2005. Defensins and other antimicrobial peptides: a historical perspective and an update. Comb. Chem. High Throughput Screen. 8:209-217.
11. Ganz, T., and R. I. Lehrer. 1998. Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 10:41-44.
12. Gardete, S., S. W. Wu, S. Gill, and A. Tomasz. 2006. Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:3424-3434.
13. Hancock, R. E., and D. R. Devine (ed.). 2004. Mammalian host defense peptides. Cambridge University Press, Cambridge, United Kingdom.
14. Hancock, R. E., and G. Diamond. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:402-410.
15. Hancock, R. E., T. Falla, and M. Brown. 1995. Cationic bactericidal peptides. Adv. Microb. Physiol. 37:135-175.
16. Hancock, R. E., and R. Lehrer. 1998. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:82-88.
17. Harder, J., J. Bartels, E. Christophers, and J. M. Schroder. 2001. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707-5713.
18. Kohlrausch, U., and J. V. Holtje. 1991. Analysis of murein and murein precursors during antibiotic-induced lysis of Escherichia coli. J. Bacteriol. 173:3425-3431.
19. Kordel, M., R. Benz, and H. G. Sahl. 1988. Mode of action of the staphylococcinlike peptide Pep 5: voltage-dependent depolarization of bacterial and artificial membranes. J. Bacteriol. 170:84-88. (Pubitemid 18028525)
20. Kuroda, M., H. Kuroda, T. Oshima, F. Takeuchi, H. Mori, and K. Hiramatsu. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49:807-821.
21. Lehrer, R. 2004. Overview: antimicrobial peptides, as seen from a rearview mirror, p. 5-8. In R. E. Hancock and D. R. Devine (ed.), Mammalian host defense peptides. Cambridge University Press, Cambridge, United Kingdom.
22. Lehrer, R. I., and T. Ganz. 2002. Defensins of vertebrate animals. Curr. Opin. Immunol. 14:96-102.
23. Matsuzaki, K. 2001. Molecular mechanisms of membrane perturbation by antimicrobial peptides, p. 167-182. In K. Lohner (ed.), Development of novel antimicrobial agents: emerging strategies. Horizon Scientific Press, Wymondham, United Kingdom.
24. McAleese, F., S. W. Wu, K. Sieradzki, P. Dunman, E. Murphy, S. Projan, and A. Tomasz. 2006. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate S. aureus-type resistance to vancomycin. J. Bacteriol. 188:1120-1133. (Pubitemid 43146428)
25. Mogi, T., H. Ui, K. Shiomi, S. Omura, and K. Kita. 2008. Gramicidin S identified as a potent inhibitor for cytochrome bd-type quinol oxidase. FEBS Lett. 582:2299-2302.
26. Morgera, F., N. Antcheva, S. Pacor, L. Quaroni, F. Berti, L. Vaccari, and A. Tossi. 2008. Structuring and interactions of human beta-defensins 2 and 3 with model membranes. J. Pept. Sci. 14:518-523.
27. Oren, Z., J. Hong, and Y. Shai. 1999. A comparative study on the structure and function of a cytolytic alpha-helical peptide and its antimicrobial beta-sheet diastereomer. Eur. J. Biochem. 259:360-369.
28. Oren, Z., and Y. Shai. 1998. Mode of action of linear amphipathic alphahelical antimicrobial peptides. Biopolymers 47:451-463. (Pubitemid 128637353)
29. Orlov, D., T. Hong, L. P. Menzel, R. Azimov, T. J. Falla, A. J. Waring, and R. I. Lehrer. 2009. Bactericidal mechanism of iseganan (IB-367), a rapidly acting antimicrobial protegrin peptide, abstr. C1-1805, p. 99. Abstr. 41st Intersci. Conf. Antimicrob. Agents Chemother.
30. Pag, U., M. Oedenkoven, V. Sass, Y. Shai, O. Shamova, N. Antcheva, A. Tossi, and H. G. Sahl. 2008. Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template.' J. Antimicrob. Chemother. 61:341-352.
31. Pazgier, M., D. M. Hoover, D. Yang, W. Lu, and J. Lubkowski. 2006. Human beta-defensins. Cell. Mol. Life Sci. 63:1294-1313.
32. Peschel, A., M. Otto, R. W. Jack, H. Kalbacher, G. Jung, and F. Gotz. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274:8405-8410.
33. Peschel, A., and H. G. Sahl. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
34. Pietiainen, M., P. Francois, H. L. Hyyrylainen, M. Tangomo, V. Sass, H. G. Sahl, J. Schrenzel, and V. P. Kontinen. 2009. Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics 10:429.
35. Raj, P. A., and A. R. Dentino. 2002. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol. Lett. 206:9-18.
36. Sahl, H. G. 1985. Influence of the staphylococcinlike peptide Pep 5 on membrane potential of bacterial cells and cytoplasmic membrane vesicles. J. Bacteriol. 162:833-836. (Pubitemid 15059767)
37. Sahl, H. G., U. Pag, S. Bonness, S. Wagner, N. Antcheva, and A. Tossi. 2005. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol. 77:466-475.
38. Sass, V., U. Pag, A. Tossi, G. Bierbaum, and H. G. Sahl. 2008. Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. Int. J. Med. Microbiol. 298:619-633.
39. Scheffers, D. J., and M. G. Pinho. 2005. Bacterial cell wall synthesis: new insights from localization studies. Microbiol. Mol. Biol. Rev. 69:585-607.
40. Schibli, D. J., H. N. Hunter, V. Aseyev, T. D. Starner, J. M. Wiencek, P. B. McCray, Jr., B. F. Tack, and H. J. Vogel. 2002. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J. Biol. Chem. 277:8279-8289.
41. Schneider, T., K. Gries, M. Josten, I. Wiedemann, S. Pelzer, H. Labischinski, and H. G. Sahl. 2009. The lipopeptide antibiotic friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antimicrob. Agents Chemother. 53:1610-1618.
42. Schneider, T., M. M. Senn, B. Berger-Bachi, A. Tossi, H. G. Sahl, and I. Wiedemann. 2004. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol. Microbiol. 53:675-685.
43. Schroder, J. M., and J. Harder. 2006. Antimicrobial skin peptides and proteins. Cell. Mol. Life Sci. 63:469-486.
44. Selsted, M. E., and A. J. Ouellette. 2005. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6:551-557.
45. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248. (Pubitemid 36098316)
46. Staubitz, P., H. Neumann, T. Schneider, I. Wiedemann, and A. Peschel. 2004. MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol. Lett. 231:67-71.
47. Tossi, A., and L. Sandri. 2002. Molecular diversity in gene-encoded, cationic antimicrobial polypeptides. Curr. Pharm. Des. 8:743-761.
48. Tossi, A., L. Sandri, and A. Giangaspero. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
49. van Heijenoort, J., and L. Gutmann. 2000. Correlation between the structure of the bacterial peptidoglycan monomer unit, the specificity of transpeptidation, and susceptibility to beta-lactams. Proc. Natl. Acad. Sci. U. S. A. 97:5028-5030.
50. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
51. Zelezetsky, I., A. Pontillo, L. Puzzi, N. Antcheva, L. Segat, S. Pacor, S. Crovella, and A. Tossi. 2006. Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. J. Biol. Chem. 281:19861-19871.